- Diagnostic capacity is a key challenge for most systems, and provider collaboratives are taking a lead in many areas to increase capacity by realising the unique opportunities offered by working at scale.
- Expanding diagnostic capacity is necessary nationally to meet demand, tackle long waits and recover elective performance backlogs. Sir Mike Richards' review of diagnostic services in England included a recommendation to increase capacity by establishing CDCs.
- Diagnostics has been a key area where providers have collaborated effectively to build additional capacity as they develop their role delivering system and national priorities.
- While the £2.3 billion allocated by the government to support the establishment of CDCs was very welcome, it is a limited sum given the scale of expansion needed in diagnostics across the country. However, it has helped providers to come together to jointly plan and provide CDCs. One driver for providers to collaborate on diagnostics has been to strengthen their bids for this funding, by demonstrating the impact increased investment would have on system-wide performance and the ability to meet system targets.
- The establishment of CDCs has already led to real success in increasing activity. However, two limiting factors remain: expanding capacity in systems where trusts are unable to access adequate capital or have persistent workforce shortages. Government and NHS England must also ensure sufficient investment is available for patients to complete treatment pathways in a timely fashion, once a diagnosis is made.
- Providers have also demonstrated how well they can collaborate on major capital projects, and develop shared approaches to procurement, operating models, and workforce arrangements. The delivery of CDCs – supported by clear goals and dedicated funding – shows how trusts can take a system-first approach to providing essential services for their populations.